The company will use the funds for a European feasibility study for its transcatheter device and for the launch of a ...

Michael Mack教授在2025年纽约瓣膜会议上的演讲为心血管医学界提供了重要的学术指导和思考方向。他关于"早期TAVR不会显著改变指南，需要更强证据支持"的观点，体现了一位资深专家对循证医学原则的坚持和对患者安全的高度责任感。

RATES of permanent pacemaker implantation (PPI) exceed 20% in patients with aortic regurgitation (AR). A new retrospective ...

Four complex heart surgeries were done without a single chest cut using TPVR Read ahead to know how this minimally invasive ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

Pacific TMVR market. The sector’s expansion is attributed to rising disease prevalence, technological progress, demand for ...

The agency’s decision supports broader access to a minimally invasive treatment for patients with severe tricuspid ...

Depending on procedure, the transfemoral, segment dominated the market in 2020, and this trend is expected to continue during ...

Overview of Prosthetic Heart Valve MarketThe Global Prosthetic Heart Valve Market is valued at USD 8.74 Billion in 2024 and is projected to attain a value of USD 28.96 Billion by 2035 at a CAGR of 11.

Quantification of Debris Captured Using Transcatheter Cerebral Embolic Protection During Valve in Valve Transcatheter Aortic Valve Replacement With Bioprosthetic Valve Fracture Receive the the latest ...

Israeli clinical stage medical company Restore Medical, which is developing transcatheter therapies for heart failure, has ...

A nationwide analysis of Spanish data reveals an increase in the risk for permanent pacemaker implantation following ...